2020 is a critical year for our Joint Programme as we collectively define the path to getting back on track to ending the AIDS epidemic by 2030. Our revised timelines for adoption of the next strategy are highly ambitious. We need the full support of all the tremendously dedicated people in UNAIDS-w...ithin our staff, our board and all our stakeholders to make this happen.
more
UNAIDS calls on governments to live up to their commitment to develop nationally owned and led social protection systems for all, including floors; and scale up and progressively enhance coverage, adequacy and comprehensiveness, thereby improving the responsiveness and quality of interventions to ad...dress the needs and vulnerabilities of people living with HIV.
more
UNAIDS/99.31E (English original, June 1999)
1st revision, April 2000
Bain LE, et al. BMJ Glob Health 2017;2:e000227. doi:10.1136/bmjgh-2016-000227
WHO/UNAIDS 2017 | Statement
Journal of Virus Eradication 2018; 4 (Supplement 2): 33–39
Policy Brief
published: 16 March 2018 doi: 10.3389/fpubh.2018.00069
As part of the new strategy preparation, USAID/Senegal requested assistance with a gender assessment. This study was conducted from March 20 to April 11, 2010. It was supported jointly by the Women in Development Indefinite Quantity Contract (WID IQC) Task Order 1 ShortTerm Technical Assistance and ...Training (STTA&T) and the USAID/Senegal mission. In addition to conducting a literature review, the team made site visits in the cities and towns of Dakar, Thiès, Kaolack, and Tambacounda and villages near each of them. These offered examples of key gender issues in Senegal, including gender disparities in access to education, unequal allocation of land and other productive resources, and gender-based violence (such as domestic violence, female genital cutting [FGC], and rape), as well as examples of USAID/Senegal‟s programming to address these problems.
more
This publication provides a problem analysis of the U.S. cuts in global health and derives concrete recommendations for action for medical actors. The focus is on analyzing the direct effects on health-specific development cooperation.